Unlock wellness: Exclusive discounts on services!

Unlocking Youthful Levels Of GH: Embrace Anti-Aging and Vitality Today

At Eternal Wellness, we prioritize your long-term health through holistic approaches. We focus on overall health and anti-aging protocols to keep the body and mind young! Growth Hormone production declines after puberty and continues to decline as we age. It's an extremely important hormone to keep you young, agile and fit. We don't believe in HGH therapy as it further inhibits and shuts down your own natural production, instead we focus on restoring your natural production through peptides which stimulate just that.

GHRP-2

5/8/20241 min read

This study evaluates the effects of two synthetic growth hormone-releasing peptides (GHRP-2 and Hexarelin) on various hormonal responses, comparing them to other hormonal stimulants. The key findings are:

Growth Hormone (GH) Response:
- Both GHRP-2 and Hexarelin induce a strong, dose-dependent GH response in young adults, which is greater than that elicited by growth hormone-releasing hormone (GHRH) (p < 0.05).
- In elderly subjects, GH responses to GHRP-2 and Hexarelin are lower than in young subjects (p < 0.01) but still higher than those induced by GHRH (p < 0.05).
Prolactin (PRL) Response:
- GHRP-2 and Hexarelin have a mild PRL-stimulatory effect that is dose-independent and lower than the response to thyrotropin-releasing hormone (TRH) (p < 0.01).
Age-Dependent Effects:
- While GH responses decrease with age, PRL, ACTH, and cortisol responses to GHRP-2 and Hexarelin are not influenced by age.
Specificity:
- The effects of GHRP-2 and Hexarelin are not entirely specific to GH, as they also influence PRL, ACTH, and cortisol levels.

Conclusion:

GHRP-2 and Hexarelin exhibit potent, dose- and age-dependent GH-releasing effects, surpassing the efficacy of GHRH. They also stimulate PRL, ACTH, and cortisol, although these effects are less pronounced for PRL compared to TRH and similar for ACTH/cortisol compared to hCRH. These findings highlight the broader endocrine impact of GHRP-2 and Hexarelin beyond GH stimulation.